Liquidia Corporation
Liquidia Corporation develops and commercializes human therapeutics for the treatment of pulmonary arterial hypertension (PAH) and other applications using its proprietary particle engineering technology.
Company Location
419 Davis Drive, Suite 100
Morrisville
NC
27560
P.O. Box 110085
Research Triangle Park
NC
27709
Phone
County
Region
Company Details
Company type
Year founded
2004
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
Core capabilities
Potential end market(s)
Products on market
Treprostinil Injection, the first-to-file, fully substitutable generic treprostinil for parenteral administration
Products under development
YUTREPIA, an investigational, inhaled dry powder formulation of treprostinil